共同药业: 关于公司股票交易异常波动的公告

Group 1 - The stock of Hubei Gongtong Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 30% over three consecutive trading days from July 30 to August 1, 2025 [1] - The company's board of directors conducted a verification regarding the abnormal trading situation and confirmed that there are no undisclosed significant information or major matters under planning that could affect the stock price [1][1] - The board also stated that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's rules, and previous disclosures do not require correction or supplementation [1][1]